Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 28, 2007 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4/A | 1,900 | $11.49 | 151,634 | |
| Jun 28, 2007 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,900 | $11.49 | 151,634 | |
| Jun 27, 2007 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4/A | 1,900 | $11.47 | 43,354 | |
| Jun 27, 2007 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,900 | $11.47 | 43,354 | |
| Jun 17, 2020 | Chief Medical Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 1,904 | $13.47 | 163,204 | |
| Mar 01, 2023 | Director, Executive Chairman | Open market or private sale of non-derivative or derivative security | Form 4 | 1,937 | $13.69 | 992,581 | |
| Oct 31, 2008 | Chief Operating Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 1,939 | $10.00 | 36,449 | |
| Jun 22, 2015 | SVP, Program Management | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 1,944 | -- | 19,562 | |
| Sep 03, 2021 | Principal Accounting Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 1,980 | $10.04 | 85,150 | |
| Sep 03, 2021 | Principal Accounting Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 1,980 | -- | 3,168 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.